Literature DB >> 29078135

Real-world walking in multiple sclerosis: Separating capacity from behavior.

Matthew M Engelhard1, Stephen D Patek1, John C Lach2, Myla D Goldman3.   

Abstract

BACKGROUND: Habitual physical activity (HPA) measurement addresses the impact of MS on real-world walking, yet its interpretation is confounded by the competing influences of MS-associated walking capacity and physical activity behaviors.
OBJECTIVE: To develop specific measures of MS-associated walking capacity through statistically sophisticated HPA analysis, thereby more precisely defining the real-world impact of disease.
METHODS: Eighty-eight MS and 38 control subjects completed timed walks and patient-reported outcomes in clinic, then wore an accelerometer for 7days. HPA was analyzed with several new statistics, including the maximum step rate (MSR) and habitual walking step rate (HWSR), along with conventional methods, including average daily steps. HPA statistics were validated using clinical walking outcomes.
RESULTS: The six-minute walk (6MW) step rate correlated most strongly with MSR (r=0.863, p<10-25) and HWSR (r=0.815, p<10-11) rather than average daily steps (r=0.676, p<10-11). The combination of MSR and HWSR correlated more strongly with the 6MW step rate than either measure alone (r=0.884, p<10-14). The MSR overestimated the 6MW step rate (μ=10.4, p<10-7), whereas the HWSR underestimated it (μ=-18.2, p<10-19).
CONCLUSIONS: Conventional HPA statistics are poor measures of capacity due to variability in activity behaviors. The MSR and HWSR are valid, specific measures of real-world capacity which capture subjects' highest step rate and preferred step rate, respectively.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Accelerometry; Gait disorders/ataxia; Habitual physical activity; Habitual walking performance; Multiple sclerosis; Outcomes research; Six-Minute walk

Mesh:

Year:  2017        PMID: 29078135      PMCID: PMC5695705          DOI: 10.1016/j.gaitpost.2017.10.015

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  19 in total

1.  Environmental factors associated with adults' participation in physical activity: a review.

Authors:  Nancy Humpel; Neville Owen; Eva Leslie
Journal:  Am J Prev Med       Date:  2002-04       Impact factor: 5.043

2.  Physical activity and multiple sclerosis: a meta-analysis.

Authors:  Robert W Motl; Edward McAuley; Erin M Snook
Journal:  Mult Scler       Date:  2005-08       Impact factor: 6.312

3.  Step-rate thresholds for physical activity intensity in persons with multiple sclerosis.

Authors:  Stamatis Agiovlasitis; Robert W Motl
Journal:  Adapt Phys Activ Q       Date:  2014-01       Impact factor: 2.929

4.  Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.

Authors:  Myla D Goldman; Robert W Motl; Richard A Rudick
Journal:  Ther Adv Neurol Disord       Date:  2010-07       Impact factor: 6.570

5.  Accelerometry is associated with walking mobility, not physical activity, in persons with multiple sclerosis.

Authors:  Madeline Weikert; Yoojin Suh; Abbi Lane; Brian Sandroff; Deirdre Dlugonski; Bo Fernhall; Robert W Motl
Journal:  Med Eng Phys       Date:  2011-10-02       Impact factor: 2.242

6.  Objectively quantified physical activity in persons with multiple sclerosis.

Authors:  Rachel E Klaren; Robert W Motl; Deirdre Dlugonski; Brian M Sandroff; Lara A Pilutti
Journal:  Arch Phys Med Rehabil       Date:  2013-07-29       Impact factor: 3.966

7.  Physical activity in the United States measured by accelerometer.

Authors:  Richard P Troiano; David Berrigan; Kevin W Dodd; Louise C Mâsse; Timothy Tilert; Margaret McDowell
Journal:  Med Sci Sports Exerc       Date:  2008-01       Impact factor: 5.411

8.  Accelerometry in persons with multiple sclerosis: measurement of physical activity or walking mobility?

Authors:  Madeline Weikert; Robert W Motl; Yoojin Suh; Edward McAuley; Daniel Wynn
Journal:  J Neurol Sci       Date:  2010-01-08       Impact factor: 3.181

9.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

Review 10.  Physical activity in older people: a systematic review.

Authors:  Fei Sun; Ian J Norman; Alison E While
Journal:  BMC Public Health       Date:  2013-05-06       Impact factor: 3.295

View more
  5 in total

1.  Clinically Assessed Walking Capacity Versus Real-World Walking Performance in People with Multiple Sclerosis.

Authors:  Kedar K V Mate; Nancy E Mayo
Journal:  Int J MS Care       Date:  2020-06-15

2.  What gait features influence the amount and intensity of physical activity in people with multiple sclerosis?

Authors:  Massimiliano Pau; Micaela Porta; Giancarlo Coghe; Eleonora Cocco
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

3.  Does Multiple Sclerosis Differently Impact Physical Activity in Women and Man? A Quantitative Study Based on Wearable Accelerometers.

Authors:  Massimiliano Pau; Micaela Porta; Giancarlo Coghe; Jessica Frau; Lorena Lorefice; Eleonora Cocco
Journal:  Int J Environ Res Public Health       Date:  2020-11-28       Impact factor: 3.390

4.  The Two-Minute Walk Test in Persons with Multiple Sclerosis: Correlations of Cadence with Free-Living Walking Do Not Support Ecological Validity.

Authors:  Viktoria Karle; Verena Hartung; Keti Ivanovska; Mathias Mäurer; Peter Flachenecker; Klaus Pfeifer; Alexander Tallner
Journal:  Int J Environ Res Public Health       Date:  2020-12-04       Impact factor: 3.390

Review 5.  Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes.

Authors:  Ashley Polhemus; Laura Delgado Ortiz; Gavin Brittain; Nikolaos Chynkiamis; Francesca Salis; Heiko Gaßner; Michaela Gross; Cameron Kirk; Rachele Rossanigo; Kristin Taraldsen; Diletta Balta; Sofie Breuls; Sara Buttery; Gabriela Cardenas; Christoph Endress; Julia Gugenhan; Alison Keogh; Felix Kluge; Sarah Koch; M Encarna Micó-Amigo; Corinna Nerz; Chloé Sieber; Parris Williams; Ronny Bergquist; Magda Bosch de Basea; Ellen Buckley; Clint Hansen; A Stefanie Mikolaizak; Lars Schwickert; Kirsty Scott; Sabine Stallforth; Janet van Uem; Beatrix Vereijken; Andrea Cereatti; Heleen Demeyer; Nicholas Hopkinson; Walter Maetzler; Thierry Troosters; Ioannis Vogiatzis; Alison Yarnall; Clemens Becker; Judith Garcia-Aymerich; Letizia Leocani; Claudia Mazzà; Lynn Rochester; Basil Sharrack; Anja Frei; Milo Puhan
Journal:  NPJ Digit Med       Date:  2021-10-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.